VIDEOShire to Acquire Biopharma Company Baxalta in $32B DealBy Jennifer TekneciJan 11, 2016 1:55 PM EST
MARKETSDyax (DYAX) Moving On Heavy Volume In The Pre-Market HoursBy TheStreet WireDec 3, 2015 8:36 AM EST
MARKETSTrade-Ideas: Dyax (DYAX) Is Today's Post-Market Leader StockBy TheStreet WireDec 2, 2015 5:41 PM EST
JIM CRAMER'Mad Money' Lightning Round: Northrop Grumman, Lockheed Martin Both TerrificBy Scott RuttNov 11, 2015 6:00 AM EST
JIM CRAMERJim Cramer's 'Mad Money' Recap: Winners Remain When Rates RiseBy Scott RuttNov 10, 2015 7:39 PM EST
JIM CRAMERJim Cramer's 'Mad Money' Recap: Here's How You Make Money on ValueBy Scott RuttNov 2, 2015 8:21 PM EST
VIDEOClosing Bell: HP Inc. Up on Hewlett-Packard Split; Stocks RallyBy Keris Alison LahiffNov 2, 2015 4:44 PM EST
MARKETSStocks Rally to Begin 'Pivotal' Week for Rates OutlookBy Keris Alison LahiffNov 2, 2015 4:03 PM EST
MERGERS AND ACQUISITIONSDrug Giant Shire Snaps Up Biotech Dyax for $5.9 BillionBy Laura BoardNov 2, 2015 12:35 PM EST
VIDEOMidday Report: Dyax Deal Boosts Health Care; Stocks ClimbBy Keris Alison LahiffNov 2, 2015 12:10 PM EST
STOCKSShire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug BusinessBy Adam FeuersteinNov 2, 2015 6:56 AM EST
STOCKSAnalysts' Actions -- Twitter, Oracle, Analog Devices, Eastman ChemicalBy TheStreet StaffOct 14, 2015 8:54 AM EDT
MARKETSDyax (DYAX) Highlighted As Today's Perilous Reversal StockBy TheStreet WireOct 8, 2015 9:53 AM EDT
